Pharmacy
First Long-Lasting Factor VIII Candidate in Late-Stage Clinical Trial for Treatment of Hemophilia A
The FINANCIAL -- Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (STO: SOBI) on December 6 announced that the first patient has...
Pharmacyclics Reports CLL Results from preclinical and clinical studies of its Btk Inhibitor PCI-327
The FINANCIAL -- Pharmacyclics, Inc. (Nasdaq: PCYC) on December 5 announced data from three Chronic Lymphocytic Leukemia (CLL) presentations at the American...
Roche Drug Holds Promise To Soften Some Schizophrenia Symptoms
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) on December 6 presented eight-week results from a phase II study of RG16781,...
New Phase II data from investigational compound GA101 presented at American Society of Hematology
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced on December 6 new Phase II efficacy data from the investigational compound...
Rituxan/MabThera Reduces Later Therapies By 80% For Asymptomatic Follicular Lymphoma Patients
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced on December 5 positive data from a Phase III study of Rituxan/MabThera...
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
The FINANCIAL -- Pfizer Inc. (NYSE: PFE) on December 5 announced that its Board of Directors has elected Ian C. Read, 57,...
Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug
The FINANCIAL -- Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Company Limited (TSE, 4502), on November 29 announced that following pre-New Drug Application...
Pfizer, Protalix Seek EU Approval For Gaucher Disease Drug
The FINANCIAL -- Pfizer Inc. (NYSE: PFE) and Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX, TASE: PLX) on November 29 announced the submission of...
Bayer Passes First REACH Milestone
The FINANCIAL -- Bayer has successfully completed the registration of 125 large-volume chemicals under the European Union’s REACH Regulation by...
GlaxoSmithKline to increase its shareholding in Theravance
The FINANCIAL -- GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) (the “Company”) announced on November 29 that GSK will increase its...
Roche launches new cobas blood gas analyzer
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced on November 22 to introduce its new blood gas analyzer, the cobas...
Bayer MaterialScience announces price increase for thermoplastic polyurethane resins in Asia Pacific
The FINANCIAL -- Bayer MaterialScience has announced a price increase of USD 0.35 per kilogram on TPU (thermoplastic polyurethane) resins...
Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye
The FINANCIAL -- Bayer HealthCare and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on November 22 announced that in two parallel Phase 3 studies...
POZENPA32540 Phase 1 Data Presented at The American Heart Association Scientific Sessions
The FINANCIAL -- POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today the...
Pfizer Reports Positive Results From EMPHASIS-HF Trial
The FINANCIAL -- Pfizer Inc. (NYSE: PFE) on November 14 announced results from the EMPHASIS-HF trial(1) showing a statistically significant reduction in...
ADVERTISEMENT
Popular Last 24h
-
What time is SpaceX’s Starship Flight 7 launch test on Jan. 13?
-
RFE/RL: Letter from Congress Urges U.S. Secretary of State Nominee Marco Rubio to Sanction Ivanishvili’s “Enablers”
-
Real Estate in Focus: 2025 Trends to Watch
-
Austin metro ranks among highest wildfire risk in U.S., analysis shows
-
IRS announces Jan. 27 start to 2025 tax filing season;
-
What were the most destructive wildfires in California’s history?
-
5 Things: Flyers vs. Ducks
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
